Medical Marijuana Market Size Report 2019 - 2026, Sales Volume, Revenue, Share, Growth Trend and Estimation Forecast

By Application (Muscle Spasms, Anorexia, Seizures, Nausea, Pain Management [Neuropathic Pain, Cancer Pain]), By Route of Administration (Oral, Topical, Inhalation), By Distribution Channel (Online, Dispensaries), Industry Outlook Report, Regional Analysis (U.S., Canada, Germany, U.K., France, Italy, Spain, Russia, Poland, Austria, Luxembourg, China, India, Vietnam, Japan, Tajikistan, Indonesia, Thailand, Malaysia, Australia, New Zealand, Colombia, Argentina, Bolivia, Peru, Saudi Arabia, Ethiopia, Botswana, Morocco, Nigeria)

LATEST: This report includes COVID 19 Impact Analysis of the Market

  • Report ID : MD1438
  • |
  • Pages : 240
  • |
  • Tables : 85
  • |
  • Formats :

Medical Marijuana market revenue is estimated to be $XX Billion in 2019 and shall grow with a CAGR of XX.X% during the forecast period of 2019 to 2026.

Medical Marijuana is made from extracts of the Marijuana plant for medical applications. The strong, positive R&D in the field of marijuana is likely to accelerate sales. This is especially true in certain forms of epilepsy. Consumer acceptance in various countries are likely to legalize its use. However, the challenges of some side-effects of its use will need to be addressed. Additionally, since Medical Marijuana is technically the same extract as Recreational Marijuana, checks and balances in its trade will need to be developed and implemented for a successful endeavor.  
 
Analysis by Application
According to the application, the segments are Muscle Spasms, Anorexia, Seizures, Nausea, and Pain Management. Pain Management is further classified into Neuropathic Pain and Cancer Pain. The Medical Marijuana market report notes that the lion’s share of the market is ruled by the application in Pain Management. Marijuana has very little side-effects and is thus being rapidly recommended by doctors to their patients, especially in cases of chronic pain. The Medical Marijuana market research proves that nearly 20% of American adults suffer from this ailment.
 
Analysis by Route of Administration
The three segments under Route of Administration are Oral, Topical, and Inhalation. The Medical Marijuana market share is dominated by the Inhalation route of administration, which holds nearly a 75% share. This skewed preference is because an important element of medical cannabis is best administered via the lungs.
 
Analysis by Distribution Channel
According to the distribution channel, the two main segments are Online and Dispensaries. The Medical Marijuana market size is likely to grow in the Dispensaries segment as patients prefer to make medical purchases from authorized brick and mortar stores over the Online option. The Medical Marijuana market estimation for the latter is very bullish owing to the gradual legalization of medical cannabis by various governments.

 

Analysis by Region
The Medical Marijuana market forecast is the brightest in the European region. Germany’s recent legalization of Medical Cannabis has set the ball rolling for other European nations to embrace the product as well. This is expected to create an excellent Medical Marijuana Price trend and will foster business growth.
 
The North American market is also undertaking dedicated R&D in this field and the interim results are painting a very optimistic picture for the companies in this fray. Awareness initiatives by various states will further augment product adoption.
 
Analysis by Eminent Enterprises
A few leading Medical Marijuana companies are Aphria, Inc., Aurora Cannabis, Inc., Canopy Growth Corporation, and mCig, Inc. Mergers and strategic collaborations will pave the way for the success of this industry in the forecasted period. An instance of a Backward integration took place recently when a large company bought one of its vendors to gain a competitive advantage in the extraction of a raw material. On the other hand, an example of Forward integration became the talk of the town as a Manufacturer acquired a company that dealt with the logistics and the distribution network of Medical Cannabis in Europe. This will create commercial synergy for the acquirer.

 

COVERAGE HIGHLIGHTS
•    Market Revenue Estimation and Forecast (2019 – 2026)
•    Market Production Estimation and Forecast (2019 – 2026)
•    Market Sales/Consumption Volume Estimation and Forecast (2019 – 2026)
•    Breakdown of Revenue by Segments (2019 – 2026)
•    Breakdown of Production by Segments (2019 – 2026)
•    Breakdown of Sales Volume by Segments (2019 – 2026)
•    Gross Margin and Profitability Analysis of Companies
•    Business Trend and Expansion Analysis
•    Import and Export Analysis
•    Regional Analysis and Market Data Breakdown


MARKET SEGMENTATION

By Application Outlook ($Revenue and Unit Sales, 2019-2026)
•    Muscle Spasms
•    Anorexia
•    Seizures
•    Nausea
•    Pain Management
o    Neuropathic Pain
o    Cancer Pain


By Route of Administration Outlook ($Revenue and Unit Sales, 2019-2026)
•    Oral
•    Topical
•    Inhalation

By Distribution Channel Outlook ($Revenue and Unit Sales, 2019-2026)
•    Online
•    Dispensaries

By Regional Outlook ($Revenue and Unit Sales, 2019-2026)
•    North America
o    U.S.
o    Canada
•    Europe
o    Germany
o    U.K.
o    France
o    Italy
o    Spain
o    Russia
o    Poland
o    Austria
o    Luxembourg
•    Asia-Pacific
o    China
o    India
o    Vietnam
o    Japan
o    Tajikistan
o    Indonesia
o    Thailand
o    Malaysia
o    Australia
o    New Zealand
•    Latin America
o    Colombia
o    Argentina
o    Bolivia
o    Peru
•    Middle East & Africa
o    Saudi Arabia
o    Ethiopia
o    Botswana
o    Morocco
o    Nigeria

 

Eminent Enterprises
•    ABcannMedicinals, Inc.
•    Aphria, Inc.
•    Aurora Cannabis, Inc.
•    Cannabis Sativa Inc.
•    Canopy Growth Corporation
•    Emerald Health Therapeutics Inc.
•    Green Relief Inc.
•    GW Pharmaceuticals
•    Insys Therapeutics, Inc.
•    Maricann Group, Inc.
•    mCig, Inc.
•    Medical Marijuana, Inc.
•    The Cronos Group Inc.
•    Tilray
•    United Cannabis
•    The Supreme Cannabis Company

 

CHAPTER 1:    INTRODUCTION
 

1.1.    RESEARCH METHODOLOGY
1.1.1.    Desk Research 
1.1.2.    Data Synthesis 
1.1.3.    Data Validation & Market Feedback 
1.1.4.    Data Sources 

 

CHAPTER 2:    EXECUTIVE SUMMARY
2.1.    GLOBAL MARKET OUTLOOK
2.2.    CORE INSIGHTS –DELIVERY MODEL
2.3.    CORE INSIGHTS – MEDICAL MARIJUANA
2.4.    CORE INSIGHTS – SERVICE PROVIDER
2.5.    CORE INSIGHTS – GEOGRAPHY 

 

CHAPTER 3:   MARKET OVERVIEW
 

3.1.     MARKET DEFINITION AND SCOPE
 

3.2.    KEY FORCES SHAPING THE INDUSTRY
3.2.1.    Bargaining Power of Suppliers
3.2.2.    Bargaining Power of Buyers
3.2.3.    Threat of Substitutes
3.2.4.    Threat of New Entrants

 

3.3.    MARKET DYNAMICS
3.3.1.    Drivers
             3.3.1.1.    Supply-side Drivers
             3.3.1.2.    Demand-side Drivers
3.3.2.    Restraints
3.3.3.    Opportunities

 

3.4.    INDUSTRY - ANALYSIS
3.4.1.    Political Market
3.4.2.    Environmental Market
3.4.3.    Social Market
3.4.4.    Technology Market

 

CHAPTER 4:    MARKET BACKGROUND
 

4.1.    Industry Value Chain Analysis
4.1.1.    Upstream Participants 
4.1.2.    Downstream participants

 

4.2.    Pricing Analysis and Forecast, 2019-2026
4.2.1.    By Type
4.2.2.    By Region

 

CHAPTER 5:    MEDICAL MARIJUANA MARKET, BY APPLICATION OUTLOOK
 

5.1.    Overview
5.1.1.    Market Revenue (US$ Million) and Forecast, 2019-2026

 

5.2.    Muscle Spasms
5.2.1.    Key Market Trends, Growth Factors and Opportunities
5.2.2.    Market Revenue (US$ Million) and Forecast, By Region

 

5.3.    Anorexia
5.3.1.    Key Market Trends, Growth Factors and Opportunities
5.3.2.    Market Revenue (US$ Million) and Forecast, By Region

 

5.4.     Seizures
5.4.1.    Key Market Trends, Growth Factors and Opportunities
5.4.2.    Market Revenue (US$ Million) and Forecast, By Region

 

5.5.      Nausea
5.5.1.    Key Market Trends, Growth Factors and Opportunities
5.5.2.    Market Revenue (US$ Million) and Forecast, By Region

 

5.6.    Pain Management
5.6.1.    Key Market Trends, Growth Factors and Opportunities
5.6.2.    Market Revenue (US$ Million) and Forecast, By Region

 

5.7.    Neuropathic Pain
5.7.1.    Key Market Trends, Growth Factors and Opportunities
5.7.2.    Market Revenue (US$ Million) and Forecast, By Region

 

5.8.    Cancer Pain
5.8.1.    Key Market Trends, Growth Factors and Opportunities
5.8.2.    Market Revenue (US$ Million) and Forecast, By Region

 

CHAPTER 6:    MEDICAL MARIJUANA AVIONICS MARKET BY ROUTE OF ADMINISTRATION OUTLOOK
 

6.1.    Overview
6.1.1.    Market Revenue (US$ Million) and Forecast, 2019-2026

 

6.2.    Oral
6.2.1.    Key Market Trends, Growth Factors and Opportunities
6.2.2.    Market Revenue (US$ Million) and Forecast, By Region

 

6.3.    Topical
6.3.1.    Key Market Trends, Growth Factors and Opportunities
6.3.2.    Market Revenue (US$ Million) and Forecast, By Region

 

6.4.    Inhalation
6.4.1.    Key Market Trends, Growth Factors and Opportunities
6.4.2.    Market Revenue (US$ Million) and Forecast, By Region

 

CHAPTER 7:    MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL OUTLOOK
 

7.1.    Overview
7.1.1.    Market Revenue (US$ Million) and Forecast, 2019-2026

 

7.2.    Online
7.2.1.    Key Market Trends, Growth Factors and Opportunities
7.2.2.    Market Revenue (US$ Million) and Forecast, By Region

 

7.3.    Dispensaries
7.3.1.    Key Market Trends, Growth Factors and Opportunities

 

CHAPTER 8:   MEDICAL MARIJUANA MARKET, BY GEOGRAPHY
 

8.1.    Overview
 

8.2.    North America 
8.2.1.    Key Market Trends, Growth Factors and Opportunities
8.2.2.    Market Revenue and Forecast, By Delivery Model
8.2.3.    Market Revenue and Forecast, By Agriculture Type
8.2.4.    Market Revenue and Forecast, By Service Provider
8.2.5.    Market Revenue and Forecast, By Country
8.2.6.    U.S.
            8.2.6.1.    Market Revenue and Forecast
8.2.7.    Canada
             8.2.7.1.    Market Revenue and Forecast
8.2.8.    Mexico
             8.2.8.1.    Market Revenue and Forecast

 

8.3.    Europe
8.3.1.    Market Revenue and Forecast, By Delivery Model
8.3.2.    Market Revenue and Forecast, By Agriculture Type
8.3.3.    Market Revenue and Forecast, By Service Provider
8.3.4.    Market Revenue and Forecast, By Country
8.3.5.    Germany
             8.3.5.1.    Market Revenue and Forecast
8.3.6.    UK
             8.3.6.1.    Market Revenue and Forecast
8.3.7.    France
             8.3.7.1.    Market Revenue and Forecast
8.3.8.    Italy
8.3.8.1.    Market Revenue and Forecast
8.3.9.    Spain
             8.3.9.1.    Market Revenue and Forecast
8.3.10.    Poland
              8.3.10.1.    Market Revenue and Forecast
8.3.11.    Austrai
               8.3.11.1.    Market Revenue and Forecast
8.3.12.    Luxembourg
              8.3.12.1.    Market Revenue and Forecast
8.3.13.    Rest of Europe
               8.3.13.1.    Market Revenue and Forecast

8.4.    Asia-Pacific
8.4.1.    Market Revenue and Forecast, By Delivery Model
8.4.2.    Market Revenue and Forecast, By Agriculture Type
8.4.3.    Market Revenue and Forecast, By Service Provider
8.4.4.    Market Revenue and Forecast, By Country
8.4.5.    China
             8.4.5.1.    Market Revenue and Forecast
8.4.6.    India
             8.4.6.1.    Market Revenue and Forecast
8.4.7.    Japan 
             8.4.7.1.    Market Revenue and Forecast
8.4.8.    South Korea 
             8.4.8.1.    Market Revenue and Forecast
8.4.9.    Rest of APAC
             8.4.9.1.    Market Revenue and Forecast

 

8.5.    REST OF THE WORLD
8.5.1.    Market Revenue and Forecast, By Delivery Model
8.5.2.    Market Revenue and Forecast, By Agriculture Type
8.5.3.    Market Revenue and Forecast, By Service Provider
8.5.4.    Market Revenue and Forecast, By Country
8.5.5.    Latin America 
             8.5.5.1.    Market Revenue and Forecast
8.5.6.    Middle East  
             8.5.6.1.    Market Revenue and Forecast
8.5.7.    Africa 
             8.5.7.1.    Market Revenue and Forecast

 

CHAPTER 9:    COMPETITIVE MARKET
 9.1. MEDICAL MARIJUANA MARKET, 2019

CHAPTER 10:  COMPANY PROFILES
 

10.1.    Airbus S.A.S
10.1.1.    Company Overview 
10.1.2.    Financial Performance
10.1.3.    SWOT Analysis

 

10.2.    Aviation Industry Corporation of China Ltd. (AVIC)
10.2.1.    Company Overview 
10.2.2.    Financial Performance
10.2.3.    SWOT Analysis

 

10.3.    Astronics Corporation
10.3.1.    Company Overview 
10.3.2.    Financial Performance
10.3.3.    SWOT Analysis

 

10.4.    Boeing
10.4.1.    Company Overview 
10.4.2.    Financial Performance
10.4.3.    SWOT Analysis

 

10.5.    Ball Corporation
10.5.1.    Company Overview 
10.5.2.    Financial Performance
10.5.3.    SWOT Analysis

 

10.6.    BAE Systems
10.6.1.    Company Overview 
10.6.2.    Financial Performance
10.6.3.    SWOT Analysis

 

10.7.    Cobham plc
10.7.1.    Company Overview 
10.7.2.    Financial Performance
10.7.3.    SWOT Analysis

 

10.8.    Curtiss Wright
10.8.1.    Company Overview 
10.8.2.    Financial Performance
10.8.3.    SWOT Analysis

 

10.9.    Elbit System
10.9.1.    Company Overview 
10.9.2.    Financial Performance
10.9.3.    SWOT Analysis

 

10.10.    Gramin Ltd
10.10.1.    Company Overview 
10.10.2.    Financial Performance
10.10.3.    SWOT Analysis

 

10.11.    GE Aviation
10.11.1.    Company Overview 
10.11.2.    Financial Performance
10.11.3.    SWOT Analysis

 

10.12.    Harris Corporation
10.12.1.    Company Overview 
10.12.2.    Financial Performance
10.12.3.    SWOT Analysis

 

10.13.    Honeywell International Inc.
10.13.1.    Company Overview 
10.13.2.    Financial Performance
10.13.3.    SWOT Analysis

 

10.14.    Lockheed Martin Corporation
10.14.1.    Company Overview 
10.14.2.    Financial Performance
10.14.3.    SWOT Analysis

 

10.15.    L3 Harris Corporation
10.15.1.    Company Overview 
10.15.2.    Financial Performance
10.15.3.    SWOT Analysis

 

10.16.    Meggitt PLC
10.16.1.    Company Overview 
10.16.2.    Financial Performance
10.16.3.    SWOT Analysis

 

10.17.    Northrop Grumman Corporation
10.17.1.    Company Overview 
10.17.2.    Financial Performance
10.17.3.    SWOT Analysis

 

10.18.    Nucon Aerospace
10.18.1.    Company Overview 
10.18.2.    Financial Performance
10.18.3.    SWOT Analysis

 

10.19.    Panasonic Corporation
10.19.1.    Company Overview 
10.19.2.    Financial Performance
10.19.3.    SWOT Analysis

 

10.20.    Rolls Royce
10.20.1.    Company Overview 
10.20.2.    Financial Performance
10.20.3.    SWOT Analysis

 

10.21.    Raytheon Company
10.21.1.    Company Overview 
10.21.2.    Financial Performance
10.21.3.    SWOT Analysis

 

10.22.    Saab AB
10.22.1.    Company Overview 
10.22.2.    Financial Performance
10.22.3.    SWOT Analysis

 

10.23.    Safran
10.23.1.    Company Overview 
10.23.2.    Financial Performance
10.23.3.    SWOT Analysis

 

10.24.    Thales Group
10.24.1.    Company Overview 
10.24.2.    Financial Performance
10.24.3.    SWOT Analysis

 

10.25.    Teledyne Technologies Inc.
10.25.1.    Company Overview 
10.25.2.    Financial Performance
10.25.3.    SWOT Analysis

 

10.26.    Transdigm Group Inc.
10.26.1.    Company Overview 
10.26.2.    Financial Performance
10.26.3.    SWOT Analysis

PURCHASE OPTIONS

20% Free Customization ON ALL PURCHASE

*Terms & Conditions Apply

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail sales@marketdecipher.com